+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

  • ID: 5232503
  • Report
  • December 2020
  • Region: North America
  • 106 pages
  • GMD Research
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • CMIC Co. Ltd
  • Covance Inc.
  • ICON Plc
  • IQVIA Holdings Inc.
  • Novotech Pty Ltd
  • PRA Health Sciences Inc.
  • MORE
The North American pharmaceutical CRO market is expected to grow by 7.3% annually in the forecast period and reach $37.61 billion by 2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 26 tables and 41 figures, this 106-page report “North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • CRO for Pre-clinical Development
  • CRO for Phase I Trials
  • CRO for Phase II Trials
  • CRO for Phase III Trials
  • CRO for Phase IV Trials
  • Laboratory Services
  • Consulting Services
  • Data Management Services
Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Infectious Diseases
  • Oncology
  • Metabolic Disorders
  • Cardiovascular Disorders
  • Central Nervous System
  • Respiratory Disorders
  • Gastrointestinal Disorders
  • Other Therapeutic Applications
Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes
Geographically, the following national/local markets are fully investigated:
  • U.S.
  • Canada
  • Mexico
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK North America Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • CMIC Co. Ltd
  • Covance Inc.
  • ICON Plc
  • IQVIA Holdings Inc.
  • Novotech Pty Ltd
  • PRA Health Sciences Inc.
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of North America Market by Service
3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 Segmentation of North America Market by Therapeutic Application
4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 Segmentation of North America Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 North America Market 2019-2030 by Country
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK North America Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.
8 Investing in North America Market: Risk Assessment and Management
8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of North America Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. Main Product Trends and Market Opportunities in North America Pharmaceutical CRO Market
Table 6. North America Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 7. North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 8. North America Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 9. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 10. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 11. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 12. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 13. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 14. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 15. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 16. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 17. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 18. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 19. Breakdown of North America Market by Key Vendor, 2019, %
Table 20. Charles River Laboratories: Company Snapshot
Table 21. Charles River Laboratories: Business Segmentation
Table 22. Charles River Laboratories: Product Portfolio
Table 23. Charles River Laboratories: Revenue, 2016-2018, $ bn
Table 24. Charles River Laboratories: Recent Developments
Table 25. Risk Evaluation for Investing in North America Market, 2019-2030
Table 26. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. North America Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical CRO Market
Figure 8. Primary Restraints and Impact Factors of North America Pharmaceutical CRO Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of North America Pharmaceutical CRO Market
Figure 11. Breakdown of North America Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 12. North America Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%)
Figure 13. North America Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 14. North America Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 15. North America Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 16. North America Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 17. North America Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 18. North America Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 19. North America Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 20. North America Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 21. Breakdown of North America Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 22. North America Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 23. North America Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 24. North America Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 25. North America Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 26. North America Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 27. North America Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 28. North America Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 29. North America Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 30. North America Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 31. Breakdown of North America Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 32. North America Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%)
Figure 33. North America Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 34. North America Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 35. North America Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 36. Breakdown of North America Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 37. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 38. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 39. Canada Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 40. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn
Figure 41. Growth Stage of North America Pharmaceutical CRO Industry over the Forecast Period
Note: Product cover images may vary from those shown
3 of 4
  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK Global Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll